Skip to main content
Genus PLC logo

Genus PLC — Investor Relations & Filings

Ticker · GNS ISIN · GB0002074580 LEI · 54930022EOITNKSIGH56 IL Agriculture, forestry and fishing
Open in API
Filings indexed 532 across all filing types
Latest filing 2015-03-09 Board/Management Inform…
Country GB United Kingdom
Listing IL GNS

About Genus PLC

http://www.genusplc.com/

Genus PLC is a world-leading animal genetics company that pioneers genetic improvement in livestock. The company applies cutting-edge science and biotechnology to help farmers in the dairy, beef, and pork sectors breed more productive and healthier animals. It operates through two primary businesses: ABS, which provides bovine (cattle) genetics, and PIC, which provides porcine (pig) genetics. By supplying elite genetic material, Genus enables farmers to produce high-quality milk and meat more efficiently and sustainably. The company's focus on genetic advancement also aims to improve animal wellbeing and reduce the need for antibiotics, contributing to a more sustainable global food system.

Recent filings

Filing Released Lang Actions
Director Declaration
Board/Management Information Classification · 1% confidence The document is very short (751 characters) and contains the RNS Number (9272G), indicating it is a regulatory announcement via the London Stock Exchange's RNS service. The content explicitly states a 'Director Declaration' regarding a director's new appointment at another company, which falls under insider/director transaction or governance reporting. Specifically, it announces a change related to a director's external role. This aligns best with the 'Director's Dealing' (DIRS) category if it were a trade, but since it's an announcement about a director's position change, and given the RNS source, it is a specific regulatory disclosure. However, looking at the definitions, 'Director's Dealing' (DIRS) is for personal share transactions. The closest fit for announcements about director status/roles, if not remuneration (DEF 14A), is often captured under general regulatory filings or specific governance updates. Since it is a formal announcement about a director's status/role change, and it is sourced via RNS, it is a specific regulatory disclosure. Given the options, DIRS is for trades. Since this is an announcement of a director's external appointment, and it is not a standard 10-K, ER, or IR, it is best classified as a general Regulatory Filing (RNS) or potentially Board/Management Information (MANG) if the focus was internal change. Since it is a formal RNS announcement about a director's external role, RNS is the most appropriate fallback for specific regulatory notices not covered elsewhere, although DIRS is related to directors. Given the content is a 'Director Declaration' regarding an external role, and not a trade, RNS is the safest classification for a specific, non-standard regulatory notice.
2015-03-09 English
Total Voting Rights
Regulatory Filings Classification · 1% confidence The document is very short (1020 characters) and explicitly states it is providing 'Additional information' via an 'RNS Number'. The content details the total number of issued ordinary shares and voting rights, which is a standard disclosure required under transparency rules. This type of announcement, which provides a specific regulatory update without being a full financial report, fits best under the general regulatory announcement category, RNS, as it is a direct notification to the market via the RNS system.
2015-02-27 English
Holding(s) in Company
Regulatory Filings Classification · 1% confidence The document is clearly identified by the header 'RNS Number : 6985F' and contains structured data related to changes in share ownership, specifically 'TR-1: Notifications of Major Interests in Shares'. This type of filing reports when a person or entity crosses a major shareholding threshold (in this case, crossing below 3%). This directly corresponds to the definition of 'Major Shareholding Notification' (MRQ). Although it is distributed via RNS, the specific content dictates the MRQ classification over the general RNS fallback.
2015-02-24 English
Interim Results
Interim / Quarterly Report Classification · 1% confidence The document is an 'Interim Results' announcement for Genus PLC for the six months ended 31 December 2014. It contains comprehensive financial statements, including revenue, operating profit, earnings per share, and cash flow data, as well as detailed management commentary on business performance and strategy. Since it provides substantive financial data for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report (IR). H1 2015
2015-02-24 English
Acquisition of 51% of In Vitro Brasil
Regulatory Filings Classification · 1% confidence The document begins with an 'RNS Number' and the date '16 February 2015', indicating it is a regulatory announcement disseminated via the Regulatory News Service (RNS). The content details a significant corporate action: Genus plc acquiring a 51% stake in In Vitro Brasil S.A. This is a material event concerning corporate structure and financing/acquisition activity. While it relates to M&A (TAR) or Capital/Financing (CAP), the primary nature of the filing, as indicated by the RNS header and the immediate release format, is a general regulatory announcement. Since the document is a full announcement of a transaction rather than just a notice that a report is attached (ruling 2), and it doesn't fit perfectly into the highly specific categories like 10-K, ER, or DEF 14A, the most appropriate classification is the general regulatory filing category, RNS, which serves as a fallback for such immediate corporate news releases.
2015-02-16 English
Block Listing Six Monthly Return
Share Issue/Capital Change Classification · 1% confidence The document is identified by the 'RNS Number' header and explicitly states 'This information is provided by RNS The company news service from the London Stock Exchange'. The content is a 'BLOCK LISTING SIX MONTHLY RETURN' submitted to the FCA, detailing the balance of unallotted securities under an Executive Share Option Plan for the period 01.08.14 to 31.01.15. This is a specific regulatory filing related to share schemes and listing requirements, not a general earnings release, annual report, or management change announcement. Since 'RNS' is the designated category for general regulatory announcements and this specific type of return fits best under the general regulatory umbrella when a more specific code (like SHA for share issue) doesn't perfectly capture the nature of a periodic return filing, RNS is the most appropriate classification. It is a formal regulatory submission.
2015-02-02 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.